Walleye Trading LLC Reata Pharmaceuticals Inc Put Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Put Options

17 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	SELL	$79.22 - $105.37 $2.05 Million - $2.73 Million	-25,900 Reduced 78.96%	6,900 $703,000
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $826,780 - $2.5 Million	26,800 Added 446.67%	32,800 $2.98 Million
Q4 2022 Feb 14, 2023	BUY	$22.15 - $42.11 $101,890 - $193,706	4,600 Added 328.57%	6,000 $227,000
Q3 2022 Nov 14, 2022	SELL	$19.41 - $36.49 $73,758 - $138,662	-3,800 Reduced 73.08%	1,400 $35,000
Q2 2022 Aug 08, 2022	BUY	$20.71 - $36.5 $107,692 - $189,800	5,200 New	5,200 $158,000
Q1 2022 May 16, 2022	SELL	$24.12 - $39.6 $24,120 - $39,600	-1,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $20,488 - $88,768	-800 Reduced 44.44%	1,000 $26,000
Q3 2021 Nov 15, 2021	BUY	$100.0 - $143.02 $140,000 - $200,228	1,400 Added 350.0%	1,800 $181,000
Q2 2021 Aug 16, 2021	BUY	$78.27 - $151.29 $31,308 - $60,516	400 New	400 $57,000
Q4 2020 Feb 16, 2021	SELL	$102.03 - $184.62 $163,248 - $295,392	-1,600 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$93.53 - $163.34 $84,177 - $147,006	900 Added 128.57%	1,600 $156,000
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $50,520 - $70,624	400 Added 133.33%	700 $109,000
Q1 2020 May 15, 2020	SELL	$124.16 - $247.74 $1.03 Million - $2.06 Million	-8,300 Reduced 96.51%	300 $43,000
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $633,845 - $1.85 Million	8,500 Added 8500.0%	8,600 $1.76 Million
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $108,808 - $132,090	-1,400 Reduced 93.33%	100 $9,000
Q4 2018 Feb 14, 2019	BUY	$48.76 - $76.44 $29,256 - $45,864	600 Added 66.67%	1,500 $84,000
Q3 2018 Nov 14, 2018	BUY	$35.64 - $92.06 $32,076 - $82,854	900 New	900 $74,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account